Search
for

    Sort by

    Research 181–210 of 1000+

    1. Corn silk extract improves benign prostatic hyperplasia in experimental rat model Nutrition Research and Practice · 2017 · 20 citations
    2. Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia Hormone Molecular Biology and Clinical Investigation · 2015 · 20 citations
    3. Ezetimibe Reduces Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia The Journal of Urology · 2010 · 20 citations
    4. Comparison of clinical trials with finasteride and dutasteride. PubMed · 2004 · 20 citations
    5. Novel inhibitors of 5α-reductase Expert Opinion on Therapeutic Patents · 2002 · 20 citations
    6. Synthesis of phenanthridin-3-one derivatives: Non-steroidal inhibitors of steroid 5-α-reductase Tetrahedron Letters · 1995 · 20 citations
    7. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis PLOS ONE · 2018 · 19 citations
    8. Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians Asian journal of urology · 2017 · 19 citations
    9. Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor Bioorganic & Medicinal Chemistry Letters · 2010 · 18 citations
    10. A regulatory perspective on pharmacokinetic/pharmacodynamic modelling Statistical Methods in Medical Research · 1999 · 18 citations
    11. Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm The World Journal of Men's Health · 2020 · 17 citations
    12. 5α-Reductase Inhibitors, Chemical and Clinical Models Steroids · 1998 · 17 citations
    13. FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects The Journal of Steroid Biochemistry and Molecular Biology · 1996 · 17 citations
    14. Safety aspects of androgen treatment with 5α-dihydrotestosterone Andrologia · 2007 · 16 citations
    15. Therapeutic Androgen Receptor Ligands Nuclear Receptor Signaling · 2003 · 16 citations
    16. The beneficial effects of Pumpkin (<i>Cucurbita pepo</i>L.) seed oil for health condition of men Food Reviews International · 2018 · 15 citations
    17. 5α-Reductase Inhibitors (5ARIs) and Male Reproduction Advances in Experimental Medicine and Biology · 2017 · 15 citations
    18. 5-Alpha-Reductase Inhibitors and Combination Therapy Urologic Clinics of North America · 2016 · 15 citations
    19. Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs Pharmacopsychiatry · 2015 · 15 citations
    20. α-spinasterol from Melandrium firmum attenuates benign prostatic hyperplasia in a rat model Molecular Medicine Reports · 2014 · 15 citations
    21. Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature Archivio Italiano di Urologia e Andrologia · 2020 · 14 citations
    22. Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia Therapeutic advances in urology · 2016 · 14 citations
    23. New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors Steroids · 2011 · 14 citations
    24. Synthesis and 5α-reductase inhibitory activity of 8-substituted benzo[ƒ]quinolinones derived from palladium mediated coupling reactions Bioorganic & Medicinal Chemistry Letters · 1998 · 14 citations
    25. Finasteride Induced Gynecomastia The Journal of Urology · 1997 · 14 citations
    26. Highly efficient nucleophilic addition of alkyl Grignard reagents to 17-ketosteroids in the presence of cerium(III) chloride: Synthesis of 17α-propyl-17β-hydroxy-4-androsten-3-one, an androgen receptor antagonist Tetrahedron Letters · 1994 · 14 citations
    27. Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study Urologic Oncology: Seminars and Original Investigations · 2018 · 13 citations
    28. Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids Steroids · 2015 · 13 citations
    29. PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice Canadian Urological Association Journal · 2012 · 13 citations
    30. Plasma androsterone/epiandrosterone sulfates as markers of 5α-reductase activity: Effect of finasteride in normal men Steroids · 1997 · 13 citations